| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Added value of molecular targeted agents in oncology
|
Soria, J.-C.
|
|
|
22 |
8 |
p. 1703-1716
|
article
|
| 2 |
Advanced breast cancer incidence following population-based mammographic screening
|
Autier, P.
|
|
|
22 |
8 |
p. 1726-1735
|
article
|
| 3 |
A German multicenter, randomized phase III trial comparing irinotecan–carboplatin with etoposide–carboplatin as first-line therapy for extensive-disease small-cell lung cancer
|
Schmittel, A.
|
|
|
22 |
8 |
p. 1798-1804
|
article
|
| 4 |
Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers
|
Park, S.
|
|
|
22 |
8 |
p. 1755-1762
|
article
|
| 5 |
An economic analysis of the INTEREST trial, a randomized trial of docetaxel versus gefitinib as second-/third-line therapy in advanced non-small-cell lung cancer
|
Horgan, A.M.
|
|
|
22 |
8 |
p. 1805-1811
|
article
|
| 6 |
A prospective dose-finding trial using a modified continual reassessment method for optimization of fludarabine plus melphalan conditioning for marrow transplantation from unrelated donors in patients with hematopoietic malignancies
|
Terakura, S.
|
|
|
22 |
8 |
p. 1865-1871
|
article
|
| 7 |
Are cohort data on smokeless tobacco use and pancreatic cancer confounded by alcohol use?
|
Nyrén, O.
|
|
|
22 |
8 |
p. 1930-1931
|
article
|
| 8 |
Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesis
|
Lintermans, A.
|
|
|
22 |
8 |
p. 1763-1769
|
article
|
| 9 |
Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study
|
Toriola, A.T.
|
|
|
22 |
8 |
p. 1916-1921
|
article
|
| 10 |
Circulating biomarker tissue kallikrein-related peptidase KLK5 impacts ovarian cancer patients’ survival
|
Dorn, J.
|
|
|
22 |
8 |
p. 1783-1790
|
article
|
| 11 |
Circulating tumor cells, colon cancer and bevacizumab: the meaning of zero
|
Gazzaniga, P.
|
|
|
22 |
8 |
p. 1929-1930
|
article
|
| 12 |
Comparison of RECIST and Choi criteria for computed tomographic response evaluation in patients with advanced gastrointestinal stromal tumor treated with sunitinib
|
Dudeck, O.
|
|
|
22 |
8 |
p. 1828-1833
|
article
|
| 13 |
Correction to: Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the German Society of Hematology and Oncology
|
|
|
|
22 |
8 |
p. 1936
|
article
|
| 14 |
Dietary acrylamide and pancreatic cancer risk in an Italian case–control study
|
Pelucchi, C.
|
|
|
22 |
8 |
p. 1910-1915
|
article
|
| 15 |
Editorial Board
|
|
|
|
22 |
8 |
p. ii-iii
|
article
|
| 16 |
EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors
|
Pallis, A.G.
|
|
|
22 |
8 |
p. 1922-1926
|
article
|
| 17 |
Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis
|
Barnes, J.A.
|
|
|
22 |
8 |
p. 1859-1864
|
article
|
| 18 |
Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings
|
Beck, J.
|
|
|
22 |
8 |
p. 1812-1823
|
article
|
| 19 |
Found in translation: Annals of Oncology and translational research
|
McLeod, H.L.
|
|
|
22 |
8 |
p. 1698-1699
|
article
|
| 20 |
Functional organ preservation in patients with locoregionally advanced head and neck squamous cell carcinoma treated by platinum-based multidrug induction chemotherapy and concurrent chemoradiotherapy
|
Boscolo-Rizzo, P.
|
|
|
22 |
8 |
p. 1894-1901
|
article
|
| 21 |
Letrozole withdrawal response in locally advanced breast cancer
|
Lambertini, M.
|
|
|
22 |
8 |
p. 1927-1928
|
article
|
| 22 |
Male pattern baldness and the risk of prostate cancer
|
Yassa, M.
|
|
|
22 |
8 |
p. 1824-1827
|
article
|
| 23 |
Medical oncology: the long-awaited prize of recognition
|
Casali, P.G.
|
|
|
22 |
8 |
p. 1695-1697
|
article
|
| 24 |
Phase II study of bendamustine in combination with rituximab as first-line treatment in patients 80 years or older with aggressive B-cell lymphomas
|
Weidmann, E.
|
|
|
22 |
8 |
p. 1839-1844
|
article
|
| 25 |
Randomized comparison of pegfilgrastim day 4 versus day 2 for the prevention of chemotherapy-induced leukocytopenia
|
Zwick, C.
|
|
|
22 |
8 |
p. 1872-1877
|
article
|
| 26 |
Relationship between estrogen receptor, progesterone receptor, HER-2 and Ki67 expression and efficacy of aromatase inhibitors in advanced breast cancer
|
Anderson, H.
|
|
|
22 |
8 |
p. 1770-1776
|
article
|
| 27 |
Reply to Are cohort data on smokeless tobacco use and pancreatic cancer confounded by alcohol use?
|
Bertuccio, P.
|
|
|
22 |
8 |
p. 1931-1932
|
article
|
| 28 |
Risk for second malignancies in non-Hodgkin’s lymphoma survivors: a meta-analysis
|
Pirani, M.
|
|
|
22 |
8 |
p. 1845-1858
|
article
|
| 29 |
Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab
|
Tebbutt, N.C.
|
|
|
22 |
8 |
p. 1834-1838
|
article
|
| 30 |
Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients
|
Licitra, L.
|
|
|
22 |
8 |
p. 1886-1893
|
article
|
| 31 |
Serial changes in the expression of breast cancer-related proteins in response to neoadjuvant chemotherapy
|
Chuah, B.Y.S.
|
|
|
22 |
8 |
p. 1748-1754
|
article
|
| 32 |
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
|
Goldhirsch, A.
|
|
|
22 |
8 |
p. 1736-1747
|
article
|
| 33 |
Table of Contents
|
|
|
|
22 |
8 |
p. iv-vi
|
article
|
| 34 |
The effect of exemestane, anastrozole, and tamoxifen on lipid profiles in Japanese postmenopausal early breast cancer patients: final results of National Surgical Adjuvant Study BC 04, the TEAM Japan sub-study
|
Hozumi, Y.
|
|
|
22 |
8 |
p. 1777-1782
|
article
|
| 35 |
The History of Oncology by Theo Wagener
|
Pavlidis, N.
|
|
|
22 |
8 |
p. 1933-1935
|
article
|
| 36 |
The potential role of cyclooxygenase-2 (COX-2) during early breast cancer therapy
|
Filipović, A.
|
|
|
22 |
8 |
p. 1700-1702
|
article
|
| 37 |
The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN)
|
Hristozova, T.
|
|
|
22 |
8 |
p. 1878-1885
|
article
|
| 38 |
Thymidylate synthase (TS) gene expression in primary lung cancer patients: a large-scale study in Japanese population
|
Tanaka, F.
|
|
|
22 |
8 |
p. 1791-1797
|
article
|
| 39 |
Utilization of oncology services and receipt of treatment: a comparison between patients with breast, colon, rectal, or lung cancer
|
Li, X.
|
|
|
22 |
8 |
p. 1902-1909
|
article
|
| 40 |
VEGF gene polymorphisms may be associated with an increased risk of fluorouracil-induced diarrhea
|
Formica, V.
|
|
|
22 |
8 |
p. 1928-1929
|
article
|
| 41 |
Window-of-opportunity trials to evaluate clinical activity of new molecular entities in oncology
|
Glimelius, B.
|
|
|
22 |
8 |
p. 1717-1725
|
article
|
Journal description